Skip to main content

Reevaluation of a lectin antibody ELISA kit for measuring fucosylated haptoglobin in various conditions.

Kamada Y, Kinoshita N, Tsuchiya Y, Kobayashi K, Fujii H, Terao N, Kamihagi K, Koyama N, Yamada S, Daigo Y, Nakamura Y, Taniguchi N, Miyoshi E

Publication: Clin Chim Acta (2013) • Vol 417 • Page 48-53PMID: 23262369View on PubMed

Purpose

The purpose of this paper was to determine the effects of specimen dilution, the use of plasma rather than serum, and anticoagulant type on the measurement of fucosylated haptoglobin (Fuc-Hpt) using a lectin antibody ELISA kit. Possible assay interference by formagine, hemoglobin, and free or conjugated bilirubin was also evaluated.

Conclusion

Fuc-Hpt levels were significantly higher when measured in serum than in plasma, regardless of anticoagulant. The highest correlation between serum Fuc-Hpt and plasma Fuc-Hpt levels was observed when plasma was anticoagulated with heparin. Dilution of serum from healthy volunteers beyond 100-fold led to Fuc-Hpt measurements at or below background level. However, because Fuc-Hpt levels were significantly higher among specimens from pancreatic cancer patients, dilution of serum from pancreatic cancer patients by 125-fold yielded the best results for the ELISA, with high correlations observed between data from the 125-fold dilution and 25-fold or 625-fold dilutions. The addition of formagine or free or conjugated bilirubin did not interfere with the Fuc-Hpt lectin antibody ELISA kit, however, the addition of hemoglobin caused Fuc-Hpt measurements to decrease in a concentration dependent manner.

Studies (1)

Purpose

The purpose of this study was to determine the effects of specimen dilution, the use of plasma rather than serum, and anticoagulant type on the measurement of Fuc-Hpt by ELISA. Possible assay interference by formagine, hemoglobin, and free or conjugated bilirubin was also evaluated. Plasma and serum were stored at -80 degrees C until analysis.

Summary of Findings

Fuc-Hpt levels were significantly higher when measured in serum than in plasma, regardless of anticoagulant (all p<0.0001). The highest correlation between serum Fuc-Hpt and plasma Fuc-Hpt levels was observed when plasma was anticoagulated with heparin (r=0.96), and correlations between serum Fuc-Hpt and citrate and EDTA plasma were r=0.85 and r=0.90, respectively. Dilution of serum from healthy volunteers beyond 100-fold led to Fuc-Hpt measurements at or below the background level of the assay. However, because Fuc-Hpt levels were significantly higher among specimens from pancreatic cancer patients (p<0.01), dilution of serum from pancreatic cancer patients to 125-fold yielded the best results for the ELISA, with high correlations observed between data from the 125-fold dilution and 25-fold or 625-fold dilutions. The addition of formagine or free or conjugated bilirubin did not interfere with the Fuc-Hpt ELISA kit, however, the addition of hemoglobin caused Fuc-Hpt measurements to decrease in a concentration dependent manner.

  • Biospecimens

    FluidPlasma
    FluidSerum
    FluidBlood
  • Preservation Types

    Frozen
  • Diagnoses

    Normal
    NeoplasticCarcinoma
  • Platforms

    ProteinELISA
  • Pre-analytical Factors

    ClassificationPre-Analytical FactorValue(s)
    Biospecimen AcquisitionAnticoagulant
    Citrate
    EDTA
    Heparin
    Biospecimen Aliquots and ComponentsAliquot size/volume
    Diluted 2- to 300-fold
    Diluted 5- to 78,125-fold
    Biospecimen Aliquots and ComponentsBiospecimen components
    Pooled sera plus conjugated bilirubin
    Pooled sera plus formagine
    Pooled sera plus free bilirubin
    Pooled sera plus hemoglobin
    Biospecimen Aliquots and ComponentsBlood and blood products
    Plasma
    Serum